Association of HIV viral load and CD4 cell count with human papillomavirus detection and clearance in HIV-infected women initiating highly active antiretroviral therapy

HIV Medicine

Volumn 13, Issue 6, 2012, Pages 372-378

  Kang, M ^a   Cu Uvin, S ^b  

^a CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Cervical cancer; HAART; HIV; Human papillomavirus; Markov models

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; VIRUS RNA;

ARTICLE; CD4 LYMPHOCYTE COUNT; HIGH RISK POPULATION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INFECTION CONTROL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; VIRAL CLEARANCE; VIRUS DETECTION; VIRUS LOAD; VIRUS TYPING; WART VIRUS;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV SEROPOSITIVITY; HIV-1; HUMANS; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; RETROSPECTIVE STUDIES; VAGINAL SMEARS; VIRAL LOAD;

EID: 84861802223     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2011.00979.x     Document Type: Article

References (17)

1. Ahdieh L, Klein RS, Burk R etal. Prevalence, incidence, and type-specific persistence of human papillomavirus in human immunodeficiency virus (HIV)-positive and HIV-negative women. J Infect Dis 2001; 184: 682-690.
2. Schuman P, Ohmit SE, Klein RS etal. Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis 2003; 188: 128-136.
3. Massad LS, Ahdieh L, Benning L etal. Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study. J Acquir Immune Defic Syndr 2001; 27: 432-442.
4. Strickler HD, Burk RD, Fazzari M etal. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst 2005; 97: 577-586.
5. Ellerbrock TV, Chiasson MA, Bush TJ etal. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000; 283: 1031-1037.
6. Minkoff H, Ahdieh L, Massad LS etal. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 2001; 15: 2157-2164.
7. Kang M, Lagakos SW. Statistical methods for panel data from a semi-Markov process, with application to HPV. Biostatistics 2007; 8: 252-264.
8. Wacholder S. Chapter 18: statistical issues in the design and analysis of studies of human papillomavirus and cervical neoplasia. J Natl Cancer Inst Monogr 2003; 31: 125-130.
9. Fife KH, Wu JW, Squires KE, Watts DH, Andersen JW, Brown DR. Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2009; 51: 274-282.
10. Munoz N, Bosch FX, de Sanjose S etal. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
11. Bouvard V, Baan R, Straif K etal. A review of human carcinogens - Part B: biological agents. Lancet Oncol 2009; 10: 321-322.
12. Kalbfleisch J, Lawless J. The analysis of panel data under a Markov assumption. J Am Stat Assoc 1985; 80: 863-871.
13. Heard I, Palefsky JM, Kazatchkine MD. The impact of HIV antiviral therapy on human papillomavirus (HPV) infections and HPV-related diseases. Antivir Ther 2004; 9: 13-22.
14. Paramsothy P, Jamieson DJ, Heilig CM etal. The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol 2009; 113: 26-31.
15. Clarke B, Chetty R. Postmodern cancer: the role of human immunodeficiency virus in uterine cervical cancer. Mol Pathol 2002; 55: 19-24.
16. De Vuyst H, Lillo F, Broutet N, Smith JS. HIV, human papillomavirus, and cervical neoplasia and cancer in the era of highly active antiretroviral therapy. Eur J Cancer Prev 2008; 17: 545-554.
17. Dolei A, Curreli S, Marongiu P etal. Human immunodeficiency virus infection in vitro activates naturally integrated human papillomavirus type 18 and induces synthesis of the L1 capsid protein. J Gen Virol 1999; 80: (Pt 11):2937-2944.